kidney failure

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to kidney-failure and about 366282 articles are being published on the current trends in kidney-failure. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to justice studies and kidney-failure are being carried out. As reported in article Hiromichi Suzuki- Effect of Hemoglobin Target on Progression of Chronic Kidney Disease-Several large scale clinical trials investigating the correction of anemia with a higher hemoglobin (Hb) levels (>13 g/dL) failed to show that therapy with erythropoiesis-stimulating agents (ESA) prevented the progression of renal dysfunction. Besides, one reason for failure of preservation is excessive elevation of Hb. In contrast to these demonstrations, two studies in Japan reported the renoprotective property of higher levels of Hb. Kuriyama reported that achieving Hb levels (11-13 g/dL) higher than the conventional target of approximately 10 g/dL with ESA prevented the progression of renal function in patients with chronic kidney disease (CKD). Tsubakihara recently demonstrated that maintaining higher Hb levels (11.0